Canaccord Adams
http://www.canaccordadams.com/default.htmCanaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, their 225 professionals seek out emerging opportunities in their key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate and Gaming, Consumer and Industrial Growth. Located in nine offices internationally, their experienced team generates focused, actionable ideas that identify opportunity and facilitate growth.
View Older Stories View More Recent Stories
-
Canaccord Reiterates Buy on Research In Motion (RIMM); $225 PT
-
Canaccord Adams Reiterates Sell on Amylin (AMLN)
-
Wall Street Throws In the Towel On Amylin (AMLN) Following New Byetta Patient Deaths
-
Canaccord Adams Lowers Price Target on Amylin (AMLN) to $20
-
Canaccord Remains Bullish on Google (GOOG) Following Search Engine Strategies Conference
-
Olympic Hangover Could Sink Shares of Baidu (BIDU) -Canaccord Adams
-
Canaccord Reiterates Sell on Amylin (AMLN) Following Byetta Issues
-
Canaccord Bullish on First Solar (FSLR) Following Facility Expansion News
-
Canaccord Adams Notes Herbalife (HLF) May Have Hired a Banker and USANA's General Counsel
-
Canaccord Ups Price Target on Canadian Solar to $44 (CSIQ)
-
Canaccord Adams Starts St. Jude Medical (STJ) at Hold
-
Canaccord Adams Starts AtriCure (ATRC) at Buy; $15 PT
-
Canaccord Adams Starts Real Goods Solar (RSOL) at Speculative Buy
-
Canaccord Adams Downgrades SiRF Technology (SIRF) to Hold
-
Hansen Natural (HANS) Puts Active; Shares Rally Off of 30-Month Lows After EPS
-
Canaccord Adams Starts Exactech (EXAC) at Buy
-
Canaccord Adams Starts Inverness Medical Innovations (IMA) at Buy
-
Canaccord Adams Boosts Price Target on Blackboard (BBBB) to $48
-
Canaccord Adams Upgrades Internap Networks (INAP) to Hold
-
Canaccord Slashes PT on Whole Foods Market (WFMI) to $23
-
Canaccord Downgrades Idera Pharma (IDRA) to Hold
-
Canaccord Downgrades Exelixis (EXEL) to Hold
-
Canaccord Cuts Price Target on Priceline.com (PCLN) to $110
-
Canaccord Downgrades Microvision (MVIS) to Hold
-
Canaccord Adams Starts Solarfun Power (SOLF) at Hold
-
Canaccord Adams Starts JA Solar Holdings (JASO) at Buy
-
Canaccord Adams Starts Canadian Solar (CSIQ) at Buy
-
Canaccord Adams Trims Target on Data Domain (DDUP) to $30, Maintains Buy
-
Canaccord Adams Boosts Price Target on NetScout Systems (NTCT) to $18.50
-
Canaccord Adams Boosts Price Target on Newfield Exploration (NFX) to $90
-
Canaccord Adams Trims Price Target on Freeport-McMoRan (FCX) to $131, Maintains Buy
-
Canaccord Adams Downgrades Zimmer Holdings (ZMH) to Hold
-
Canaccord Adams Downgrades Cerner (CERN) to Hold
-
Canaccord Reiterates Buy on Potash (POT)
-
Vale (RIO) Sinks Despite Goldman Upgrade, Barron's Tout
-
Research In Motion (RIMM) Seeing No Adverse Impact From iPhone 3G Launch - Canaccord Adams
-
Pharmasset (VRUS) Prices 1.45M Shares at $17.85/Share in Registered Direct Offering
-
Canaccord Adams Sees 'Notable' Q2 Upside for Google (GOOG)
-
Canaccord Adams Downgrades SucesssFactors (SFSF) to Sell
-
Hansen Natural (HANS) Lower Following Business Outlook
-
Back Up The Truck On Research In Motion (RIMM) - Canaccord Adams
-
Canaccord Adams Starts Mosaic (MOS) at Buy
-
Canaccord Adams Starts Potash (POT) at Buy; Sees A Possible Double
-
Canaccord Adams Starts Agrium (AGU) at Buy
-
Zonare Medical Systems (ZONE) Files $86.25M IPO
-
Canaccord Adams Starts LoJack (LOJN) at Sell
-
Canaccord Adams Boosts Price Target on Research In Motion (RIMM), Buy On Pullback
-
Cano Petroleum (CFW) to Sell 7M Shares in Public Offering
-
Canaccord Adams Upgrades Yahoo! (YHOO) to Hold, Sees Potential Positives Building
-
Color on Canaccord Downgrade of Insulet (PODD)

